Promiscuous mechanisms underlie the antitumor effects of thalidomide analogs
Nat Med
.
2016 Jul 7;22(7):706-7.
doi: 10.1038/nm.4144.
Authors
P Leif Bergsagel
1
,
Marta Chesi
1
Affiliation
1
Mayo Clinic Comprehensive Cancer Center, Scottsdale, Arizona, USA.
PMID:
27387882
DOI:
10.1038/nm.4144
No abstract available
Publication types
Comment
MeSH terms
Humans
Thalidomide / analogs & derivatives*
Substances
Thalidomide
Grants and funding
P50 CA186781/CA/NCI NIH HHS/United States
R01 CA195688/CA/NCI NIH HHS/United States